[1] Moennig V,Floegel-Niesmann G,Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever:a review of new knowledge[J]. Vet J,2003,165 (1):11-20.[2] Meyers G,Thiel HJ. Molecular characterization of pestiviruses[J]. Adv Virus Res,1996,47 (1):53-118.[3] Depner KR,Hinrichs U,Bickhardt K,et al. Influence of breed-related factors on the course of classical swine fever virus infection[J]. Vet Rec, 1997,140 (19):506-507.[4] Greiser-Wilke I,Moennig V,Coulibaly CO,et al. Identification of conserved epitopes on a hog cholera virus protein[J]. Arch Virol, 1990,111 (3/4):213-225.[5] Ghildiyal M,Zamore PD. Small silencing RNAs:an expanding universe [J]. Nat Rev Genet,2009,10 (2):94-108.[6] Stege A,Priebsch A,Nieth C,et al. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference[J]. Cancer Gene Ther, 2004,11 (11):699-706.[7] 尹志华,李 峰,杨旭宇,等. 利用报道基因检测鼻咽癌细胞的RNA干扰作用[J]. 癌症,2005,(3):371-375.[8] Hasuwa H,Kaseda K,Einarsdottir T,et al. Small interfering RNA and gene silencing in transgenic mice and rats[J]. FEBS Lett,2002, 532 (1/2):227-230.[9] 王铁东,李 莉,逄大新,等. 质粒载体表达抑制猪瘟病毒shRNA在猪胚胎成纤维细胞上的复制[J]. 中国兽医学报,2009,29 (3):245-248.[10] 冶贵生,张彦明,徐 浩,等. 靶向猪瘟病毒NS3基因shRNA干扰载体的构建与鉴定[J]. 西北农林科技大学学报:自然科学版,2007, 35 (3):7-10.[11] Nagashima H,Fujimura T,Takahagi Y,et al. Development of efficient strategies for the production of genetically modified pigs[J]. Therioge-nology,2003,59 (1):95-106.[12] 王铁东. 抗猪瘟病毒转基因猪的构建及初步研究[D]. 吉林大学,2009.[13] 樊娜娜,杨东山,赖良学. 克隆猪技术及其在转基因猪研究中的应用[J]. 生命科学,2009,21 (5):652-657.[14] Lee GS,Hyun SH,Kim HS,et al. Improvement of a porcine somatic cell nuclear transfer technique by optimizing donor cell and recipient oocyte preparations[J]. Theriogenology,2003,59 (9):1949-1957.[15] Elbashir SM,Lendeckel W,Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs[J]. Genes Dev,2001,15 (2):188-200.[16] Reynolds A,Leake D,Boese Q,et al. Rational siRNA design for RNA interference[J]. Nat Biotechnol,2004,22 (3):326-330.[17] Xu X,Guo H,Xiao C,et al. In vitro inhibition of classical swine fever virus replication by siRNAs targeting Npro and NS5B genes[J]. Antiviral Res,2008,78 (3):188-193.[18] Popescu CI,Callens N,Trinel D,et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly[J]. PLoS Pathog,2011,7 (2):e1001278.[19] Raney KD,Sharma SD,Moustafa IM,et al. Hepatitis C virus non-structural protein 3 (HCV NS3):a multifunctional antiviral target[J]. J Biol Chem,2010,285 (30):22725-22731.[20] 李江南. RNA干扰途径抗猪瘟病毒研究[D]. 长春:吉林大学,2011.[21] Dillon N,Festenstein R. Unravelling heterochromatin:competition between positive and negative factors regulates accessibility[J]. Trends Genet,2002,18 (5):252-258.[22] Wilson C,Bellen HJ,Gehring WJ. Position effects on eukaryotic gene expression[J]. Annu Rev Cell Biol,1990,6 (5):679-714.[23] Liu YG,Chen Y. High-efficiency thermal asymmetric interlaced PCR for amplification of unknown flanking sequences[J]. Biotechniques, 2007,43 (5):649-654.[24] 李 莉,李小平,任林柱,等. hiTAIL-PCR技术鉴定转基因猪整合位点的研究[J]. 中国兽医学报,2010,30 (9):1235-1238.[25] 孔庆然. 转基因猪中外源基因拷贝数和整合位点的研究[D]. 哈尔滨:东北农业大学,2009.[26] Bode J,Schlake T,Iber M,et al. The transgeneticist’s toolbox:novel methods for the targeted modification of eukaryotic genomes[J]. Biol Chem,2000,381 (9/10):801-813.[27] Koch KS,Aoki T,Wang Y,et al. Site-specific integration of targeted DNA into animal cell genomes[J]. Gene,2000,249 (1/2):135-144.[28] Kito M,Itami S,Fukano Y,et al. Construction of engineered CHO strains for high-level production of recombinant proteins[J]. Appl Microbiol Biotechnol,2002,60 (4):442-448.[29] Vergunst AC,Jansen LE,Hooykaas PJ. Site-specific integration of Agrobacterium T-DNA in Arabidopsis thaliana mediated by Cre recombinase[J]. Nucleic Acids Res,1998,26 (11):2729-2734.[30] Clark KJ,Carlson DF,Foster LK,et al. Enzymatic engineering of the porcine genome with transposons and recombinases[J]. BMC Biotechnol, 2007,7 (1):42.[31] 罗一博. PiggyBac转座子介导外源基因在猪成纤维细胞及胚胎中表达研究[D]. 哈尔滨:东北农业大学,2011.[32] Jackson AL,Bartz SR,Schelter J,et al. Expression profiling reveals off-target gene regulation by RNAi[J]. Nature Biotechnol,2003,21: 635-637.[33] 邹凌云,王正志. siRNA脱靶效应研究进展[J]. 生物技术通报,2007,10 (4):59-63.[34] Manoharan M. RNA interference and chemically modified small interfering RNAs[J]. Curr Opin Chem Biol,2004,8 (6):570-579.[35] Das AT,Brummelkamp TR,Westerhout EM,et al. Human immu-nodeficiency virus type 1 escapes from RNA interference-mediated inhibition[J]. J Virol,2004,78 (5):2601-2605.[36] Westrhout EM,Ooms M,Vink M,et al. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome[J]. Nucleic Acids Res,2005,33 (2):796-804.[37] Li J,Dai Y,Liu S,et al. In vitro inhibition of CSFV replication by multiple siRNA expression[J]. Antivir Res,2011,91 (2):209-216.[38] 王继英,杜立新. 转基因动物制作及提高外源基因表达的策略[J]. 中国畜牧兽医,2002,29 (2):30-34.[39] Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development[J]. Nature,2007,447 (7143):425-432. |